Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial.
Eptinezumab Plus Patient Education Reduces Monthly Migraine Days in Chronic Migraine With Medication Overuse — In adults with chronic migraine complicated by medication-overuse headache, eptinezumab combined with a brief educational intervention reduced monthly migraine days by 6.